MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.trim.2024.102130

Медицинская библиотека · Transplant immunology · 2024

Combination of trimethoprim-sulfamethoxazole and mesenchymal stem cell therapy to treat toxoplasmic encephalitis after hematopoietic stem cell transplantation: A case report.

Ji Qi, Liu Minyuan, Gao Li, Zhang Senlin, Zhang Weiliang, Wang Manli, Xia Zihao, Li Bohan, Kong Lingjun, Yao Yanhua, Wang Yi, Li Jie, Yan Qing, Wu Shuiyan, Liu Hu, Hu Shaoyan

Клинический случайСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Toxoplasmosis, caused by the parasite Toxoplasma gondii, is a life-threatening infection that may occur following hematopoietic stem cell transplantation (HSCT). Toxoplasmic encephalitis (TE) is one of the most severe manifestations of this infection and often results in unsatisfactory therapeutic outcomes, especially regarding neurological damage. Recent studies have demonstrated that human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) can significantly aid in neural repair and remodeling. Furthermore, hUC-MSCs have been shown to reduce the risk of graft-versus-host disease (GVHD) associated with the reduction or discontinuation of immunosuppressive therapy. In this case report, we present a pediatric patient who developed TE as a complication of haploidentical HSCT. The patient received a combined treatment regimen of standard anti-Toxoplasma therapy and adjunctive hUC-MSC therapy. The outcomes were satisfactory. The patient regained consciousness, maintained a stable body temperature, and regained the ability to perform daily activities independently. Additionally, next-generation sequencing revealed a decrease in Toxoplasma DNA sequences in the blood and cerebrospinal fluid to undetectable levels. This case report underscores the potential of hUC-MSCs as a promising therapeutic modality for TE.

Для цитирования: Ji Qi, Liu Minyuan, Gao Li, Zhang Senlin, Zhang Weiliang, Wang Manli, Xia Zihao, Li Bohan, Kong Lingjun, Yao Yanhua, Wang Yi, Li Jie, Yan Qing, Wu Shuiyan, Liu Hu, Hu Shaoyan. Combination of trimethoprim-sulfamethoxazole and mesenchymal stem cell therapy to treat toxoplasmic encephalitis after hematopoietic stem cell transplantation: A case report.. Transplant immunology. 2024. DOI: 10.1016/j.trim.2024.102130.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.